Venus Remedies Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Operating Revenue	7,028	6,479	6,014	5,555	6,002	5,481
Revenue	7,028	6,479	6,014	5,555	6,002	5,481
Revenue Growth (YoY)	8.45%	7.72%	8.27%	-7.44%	9.50%	60.90%
Cost of Revenue	3,722	3,801	3,564	3,329	3,870	3,408
Gross Profit	3,306	2,678	2,451	2,226	2,132	2,073
Selling, General & Admin	2,023	1,862	1,697	1,397	1,281	1,378
Research & Development	177.65	180.85	158.4	228.85	230.3	157.58
Other Operating Expenses	-89.82	-89.82	-5.08	-4.86	-4.63	-7.8
Operating Expenses	2,347	2,178	2,114	1,944	1,842	1,880
Operating Income	959.05	500.05	336.65	282.13	290.43	192.81
Interest Expense	-0.45	-0.65	-0.94	-1.18	-3.03	-70.1
Interest & Investment Income	45.42	45.42	41.66	18.99	8.16	1.22
Currency Exchange Gain (Loss)	50.07	50.07	59.54	73.24	64.15	64.95
Other Non Operating Income (Expenses)	-34.53	7.97	4.01	6.04	4.37	62.24
EBT Excluding Unusual Items	1,020	602.85	440.92	379.22	364.08	251.11
Gain (Loss) on Sale of Investments	16.28	16.28	5.51	0.08	-	-
Other Unusual Items	0.03	99.13	-	-	-	234.42
Pretax Income	1,036	718.27	446.43	379.3	364.08	485.53
Income Tax Expense	273.02	265.12	161.53	113.65	-43.16	-132.12
Net Income	762.85	453.15	284.91	265.66	407.24	617.65
Net Income to Common	762.85	453.15	284.91	265.66	407.24	617.65
Net Income Growth	118.83%	59.05%	7.25%	-34.77%	-34.07%	-
Shares Outstanding (Basic)	13	13	13	13	13	12
Shares Outstanding (Diluted)	13	13	13	13	13	12
Shares Change (YoY)	-0.04%	-	-	1.30%	6.92%	-
EPS (Basic)	57.08	33.90	21.31	19.87	30.86	50.04
EPS (Diluted)	57.08	33.90	21.31	19.87	30.86	50.04
EPS Growth	118.95%	59.08%	7.22%	-35.60%	-38.33%	-
Free Cash Flow	-	768.15	279.67	288.09	273.94	1,241
Free Cash Flow Per Share	-	57.47	20.92	21.55	20.76	100.56
Gross Margin	47.04%	41.34%	40.75%	40.07%	35.52%	37.83%
Operating Margin	13.64%	7.72%	5.60%	5.08%	4.84%	3.52%
Profit Margin	10.85%	6.99%	4.74%	4.78%	6.78%	11.27%
Free Cash Flow Margin	-	11.86%	4.65%	5.19%	4.56%	22.64%
EBITDA	1,104	696.01	601.08	605.1	625.77	545.57
EBITDA Margin	15.70%	10.74%	9.99%	10.89%	10.43%	9.95%
D&A For EBITDA	144.61	195.96	264.43	322.98	335.34	352.76
EBIT	959.05	500.05	336.65	282.13	290.43	192.81
EBIT Margin	13.64%	7.72%	5.60%	5.08%	4.84%	3.52%
Effective Tax Rate	26.36%	36.91%	36.18%	29.96%	-	-
Revenue as Reported	7,196	6,688	6,130	5,658	6,085	5,678
Advertising Expenses	-	104.31	132.54	84.83	44.26	25.75

Source: S&P Global Market Intelligence. Standard template. Financial Sources.